Bagnasco, D.; De Ferrari, L.; Bondi, B.; Candeliere, M.G.; Mincarini, M.; Riccio, A.M.; Braido, F.
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy. Int. J. Mol. Sci. 2024, 25, 5972.
https://doi.org/10.3390/ijms25115972
AMA Style
Bagnasco D, De Ferrari L, Bondi B, Candeliere MG, Mincarini M, Riccio AM, Braido F.
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy. International Journal of Molecular Sciences. 2024; 25(11):5972.
https://doi.org/10.3390/ijms25115972
Chicago/Turabian Style
Bagnasco, Diego, Laura De Ferrari, Benedetta Bondi, Maria Giulia Candeliere, Marcello Mincarini, Anna Maria Riccio, and Fulvio Braido.
2024. "Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy" International Journal of Molecular Sciences 25, no. 11: 5972.
https://doi.org/10.3390/ijms25115972
APA Style
Bagnasco, D., De Ferrari, L., Bondi, B., Candeliere, M. G., Mincarini, M., Riccio, A. M., & Braido, F.
(2024). Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy. International Journal of Molecular Sciences, 25(11), 5972.
https://doi.org/10.3390/ijms25115972